Pharmaceuticals (May 2021)

Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties

  • Kseniya Kovaleva,
  • Olga Yarovaya,
  • Konstantin Ponomarev,
  • Sergey Cheresiz,
  • Amirhossein Azimirad,
  • Irina Chernyshova,
  • Alexandra Zakharenko,
  • Vasily Konev,
  • Tatiana Khlebnikova,
  • Evgenii Mozhaytsev,
  • Evgenii Suslov,
  • Dmitry Nilov,
  • Vytas Švedas,
  • Andrey Pokrovsky,
  • Olga Lavrik,
  • Nariman Salakhutdinov

DOI
https://doi.org/10.3390/ph14050422
Journal volume & issue
Vol. 14, no. 5
p. 422

Abstract

Read online

In this paper, a series of novel abietyl and dehydroabietyl ureas, thioureas, amides, and thioamides bearing adamantane moieties were designed, synthesized, and evaluated for their inhibitory activities against tyrosil-DNA-phosphodiesterase 1 (TDP1). The synthesized compounds were able to inhibit TDP1 at micromolar concentrations (0.19–2.3 µM) and demonstrated low cytotoxicity in the T98G glioma cell line. The effect of the terpene fragment, the linker structure, and the adamantane residue on the biological properties of the new compounds was investigated. Based on molecular docking results, we suppose that adamantane derivatives of resin acids bind to the TDP1 covalent intermediate, forming a hydrogen bond with Ser463 and hydrophobic contacts with the Phe259 and Trp590 residues and the oligonucleotide fragment of the substrate.

Keywords